Rheumatoid Arthritis, Osteoarthritis, and Crystal Arthropathies. Part of the Musculoskeletal series of the Reflex PM&R Board Review podcast. The full companion chapter and a linked board-style Q-bank set for this topic are at https://www.reflexpmr.com/read/MSK-20.

SLE, Inflammatory Myopathies, and Scleroderma. Part of the Musculoskeletal series of the Reflex PM&R Board Review podcast. The full companion chapter and a linked board-style Q-bank set for this topic are at https://www.reflexpmr.com/read/MSK-21.

Spondyloarthropathies and Fibromyalgia. Part of the Musculoskeletal series of the Reflex PM&R Board Review podcast. The full companion chapter and a linked board-style Q-bank set for this topic are at https://www.reflexpmr.com/read/MSK-22.

Osteoporosis Part 1: Diagnosis, DEXA, Risk Factors. Part of the Musculoskeletal series of the Reflex PM&R Board Review podcast. The full companion chapter and a linked board-style Q-bank set for this topic are at https://www.reflexpmr.com/read/MSK-23.

Osteoporosis Part 2: Treatment and Fracture Management. Part of the Musculoskeletal series of the Reflex PM&R Board Review podcast. The full companion chapter and a linked board-style Q-bank set for this topic are at https://www.reflexpmr.com/read/MSK-24.

MSK Ultrasound and Joint Injection. Part of the Musculoskeletal series of the Reflex PM&R Board Review podcast. Audio correction: In the audio: the timeline to memorize is three to seven days for initial onset, two to four weeks for peak effect, and three to four months for total duration — Correct: The peak is at ~3 WEEKS, not two to four weeks. Botulinum toxin for focal spasticity follows the rule of threes: onset ~3 days (24-72 hours), PEAK EFFECT ~3 WEEKS, duration ~3 months (3-4 months), with re-injection no sooner than every 3 months (12 weeks). Note MSK-25-b states the correct timeline on air (about three days / three weeks / about three months); Part A is the stale half of the pair. The written chapter is correct. The full companion chapter and a linked board-style Q-bank set for this topic are at https://www.reflexpmr.com/read/MSK-25-a.

Nerve Injury Classification and EDX Correlation. Part of the Musculoskeletal series of the Reflex PM&R Board Review podcast. Audio correction: In the audio: Wallerian degeneration was described in 1858 — Correct: Augustus Waller described Wallerian degeneration in 1850. The written chapter is correct. The full companion chapter and a linked board-style Q-bank set for this topic are at https://www.reflexpmr.com/read/MSK-26.

Salter-Harris Fractures and Pediatric MSK. Part of the Musculoskeletal series of the Reflex PM&R Board Review podcast. The full companion chapter and a linked board-style Q-bank set for this topic are at https://www.reflexpmr.com/read/MSK-27-a.

Complex Regional Pain Syndrome and Myofascial Pain. Part of the Musculoskeletal series of the Reflex PM&R Board Review podcast. The full companion chapter and a linked board-style Q-bank set for this topic are at https://www.reflexpmr.com/read/MSK-28.

BASIC-10: Neuromuscular Junction Physiology. Topics: Postsynaptic Receptor, Safety Factor, NMJ Disorders, and Neuromuscular Pharmacology — Part 2 (Part 2 of 2). Part of the Foundational Sciences series of the Reflex PM&R Board Review podcast. The full companion chapter and a linked board-style Q-bank set for this topic are at https://www.reflexpmr.com/read/BASIC-10-b.